Renewal checkout
TYLACTIN
Serial No. 87392035
- Owner
- Cambrooke Therapeutics, Inc.
- Status date
- Jul 10, 2024
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.
USPTO record
Preparing this trademark
Serial 87392035. Checking the latest USPTO record. This usually takes a few seconds.
Public reviews
Client reviews
Public Google reviews of CopyMark Law Group.
Recent filings